Department of Pediatric Nephrology, Kidney Institute, Medanta, The Medicity, Gurgaon, Haryana, India.
Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, OH, USA.
J Nephrol. 2023 Sep;36(7):1789-1804. doi: 10.1007/s40620-023-01665-1. Epub 2023 Jun 21.
Sustained low-efficiency dialysis is a hybrid form of kidney replacement therapy that has gained increasing popularity as an alternative to continuous forms of kidney replacement therapy in intensive care unit settings. During the COVID-19 pandemic, the shortage of continuous kidney replacement therapy equipment led to increasing usage of sustained low-efficiency dialysis as an alternative treatment for acute kidney injury. Sustained low-efficiency dialysis is an efficient method for treating hemodynamically unstable patients and is quite widely available, making it especially useful in resource-limited settings. In this review, we aim to discuss the various attributes of sustained low-efficiency dialysis and how it is comparable to continuous kidney replacement therapy in efficacy, in terms of solute kinetics and urea clearance, and the various formulae used to compare intermittent and continuous forms of kidney replacement therapy, along with hemodynamic stability. During the COVID-19 pandemic, there was increased clotting of continuous kidney replacement therapy circuits, which led to increased use of sustained low-efficiency dialysis alone or together with extra corporeal membrane oxygenation circuits. Although sustained low-efficiency dialysis can be delivered with continuous kidney replacement therapy machines, most centers use standard hemodialysis machines or batch dialysis systems. Even though antibiotic dosing differs between continuous kidney replacement therapy and sustained low-efficiency dialysis, reports of patient survival and renal recovery are similar for continuous kidney replacement therapy and sustained low-efficiency dialysis. Health care studies indicate that sustained low-efficiency dialysis has emerged as a cost-effective alternative to continuous kidney replacement therapy. Although there is considerable data to support sustained low-efficiency dialysis treatments for critically ill adult patients with acute kidney injury, there are fewer pediatric data, even so, currently available studies support the use of sustained low-efficiency dialysis for pediatric patients, particularly in resource-limited settings.
持续低效透析是一种肾脏替代治疗的混合形式,作为重症监护环境中连续肾脏替代治疗的替代方法,其应用日益广泛。在 COVID-19 大流行期间,连续肾脏替代治疗设备的短缺导致持续低效透析作为急性肾损伤替代治疗的应用增加。持续低效透析是治疗血流动力学不稳定患者的有效方法,且相当普及,在资源有限的环境中特别有用。在这篇综述中,我们旨在讨论持续低效透析的各种特性,以及它在疗效方面如何与连续肾脏替代治疗相媲美,包括在溶质动力学和尿素清除方面,以及用于比较间歇和连续肾脏替代治疗的各种公式,以及血流动力学稳定性。在 COVID-19 大流行期间,连续肾脏替代治疗回路的凝血增加,导致单独使用或与体外膜氧合回路一起使用持续低效透析的情况增加。虽然可以使用连续肾脏替代治疗机进行持续低效透析,但大多数中心使用标准血液透析机或批量透析系统。尽管连续肾脏替代治疗和持续低效透析的抗生素剂量不同,但连续肾脏替代治疗和持续低效透析的患者存活率和肾功能恢复报告相似。卫生保健研究表明,与连续肾脏替代治疗相比,持续低效透析是一种具有成本效益的替代方法。尽管有大量数据支持持续低效透析治疗重症成人急性肾损伤患者,但儿科数据较少,即便如此,目前可用的研究支持在资源有限的环境中为儿科患者使用持续低效透析。